Treatment modification based on basal antral follicle count maintains high pregnancy rates while preventing OHSS in egg donor IVF
To access this article, please choose from the options below
Supported by: This work was supported by EMD Serono, Inc. (an affiliate of Merck KGaA, Darmstadt, Germany), Rockland, MA.
PII: S0015-0282(09)01447-2
doi:10.1016/j.fertnstert.2009.07.011
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

